100 related articles for article (PubMed ID: 30289242)
1. Simultaneous and Independent Dual Site-Specific Self-Labeling of Recombinant Antibodies.
Wollschlaeger C; Meinhold-Heerlein I; Cong X; Bräutigam K; Di Fiore S; Zeppernick F; Klockenbring T; Stickeler E; Barth S; Hussain AF
Bioconjug Chem; 2018 Nov; 29(11):3586-3594. PubMed ID: 30289242
[TBL] [Abstract][Full Text] [Related]
2. One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology.
Hussain AF; Heppenstall PA; Kampmeier F; Meinhold-Heerlein I; Barth S
Nat Protoc; 2019 Nov; 14(11):3101-3125. PubMed ID: 31605098
[TBL] [Abstract][Full Text] [Related]
3. Detection and Specific Elimination of EGFR
Bauerschlag D; Meinhold-Heerlein I; Maass N; Bleilevens A; Bräutigam K; Al Rawashdeh W; Di Fiore S; Haugg AM; Gremse F; Steitz J; Fischer R; Stickeler E; Barth S; Hussain AF
Pharm Res; 2017 Apr; 34(4):696-703. PubMed ID: 28074431
[TBL] [Abstract][Full Text] [Related]
4. Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase.
Kampmeier F; Ribbert M; Nachreiner T; Dembski S; Beaufils F; Brecht A; Barth S
Bioconjug Chem; 2009 May; 20(5):1010-5. PubMed ID: 19388673
[TBL] [Abstract][Full Text] [Related]
5. Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein.
Kampmeier F; Niesen J; Koers A; Ribbert M; Brecht A; Fischer R; Kiessling F; Barth S; Thepen T
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1926-34. PubMed ID: 20449589
[TBL] [Abstract][Full Text] [Related]
6. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
[TBL] [Abstract][Full Text] [Related]
7. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M; Bauerschlag D; Zeppernick F; von Felbert V; Berges N; Di Fiore S; Mintert I; Bleilevens A; Maass N; Bräutigam K; Meinhold-Heerlein I; Stickeler E; Barth S; Fischer R; Hussain AF
Oncotarget; 2016 Aug; 7(34):54925-54936. PubMed ID: 27448975
[TBL] [Abstract][Full Text] [Related]
8. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
Mungra N; Biteghe FAN; Malindi Z; Huysamen AM; Karaan M; Hardcastle NS; Bunjun R; Chetty S; Naran K; Lang D; Richter W; Hunter R; Barth S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12203-12225. PubMed ID: 37432459
[TBL] [Abstract][Full Text] [Related]
9. Design and assessment of an active anti-epidermal growth factor receptor (EGFR) single chain variable fragment (ScFv) with improved solubility.
Nautiyal K; Kibria MG; Akazawa-Ogawa Y; Hagihara Y; Kuroda Y
Biochem Biophys Res Commun; 2019 Jan; 508(4):1043-1049. PubMed ID: 30551882
[TBL] [Abstract][Full Text] [Related]
10. The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.
Seifert O; Plappert A; Heidel N; Fellermeier S; Messerschmidt SK; Richter F; Kontermann RE
Protein Eng Des Sel; 2012 Oct; 25(10):603-12. PubMed ID: 22988132
[TBL] [Abstract][Full Text] [Related]
11. Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies.
Donaldson JM; Kari C; Fragoso RC; Rodeck U; Williams JC
Cancer Biol Ther; 2009 Nov; 8(22):2147-52. PubMed ID: 19783899
[TBL] [Abstract][Full Text] [Related]
12. A Macropinocytosis-Intensifying Albumin Domain-Based scFv Antibody and Its Conjugate Directed against K-Ras Mutant Pancreatic Cancer.
Wang X; Sheng W; Wang Y; Li L; Li Y; Zhang S; Liu X; Chen S; Zhen Y
Mol Pharm; 2018 Jun; 15(6):2403-2412. PubMed ID: 29757658
[TBL] [Abstract][Full Text] [Related]
13. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.
Hussain AF; Kampmeier F; von Felbert V; Merk HF; Tur MK; Barth S
Bioconjug Chem; 2011 Dec; 22(12):2487-95. PubMed ID: 21995499
[TBL] [Abstract][Full Text] [Related]
14. A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR.
von Felbert V; Bauerschlag D; Maass N; Bräutigam K; Meinhold-Heerlein I; Woitok M; Barth S; Hussain AF
J Cancer Res Clin Oncol; 2016 May; 142(5):1003-11. PubMed ID: 26847542
[TBL] [Abstract][Full Text] [Related]
15. Bioconjugates of rhizavidin with single domain antibodies as bifunctional immunoreagents.
Liu JL; Zabetakis D; Walper SA; Goldman ER; Anderson GP
J Immunol Methods; 2014 Sep; 411():37-42. PubMed ID: 24946086
[TBL] [Abstract][Full Text] [Related]
16. Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology.
Chouman K; Woitok M; Mladenov R; Kessler C; Weinhold E; Hanz G; Fischer R; Meinhold-Heerlein I; Bleilevens A; Gresch G; Haugg AM; Zeppernick F; Bauerschlag D; Maass N; Stickeler E; Kolberg K; Hussain AF
Anticancer Agents Med Chem; 2017; 17(10):1434-1440. PubMed ID: 28270070
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.
Ma C; Li Y; Li Z; Huang H; Xu K; Xu H; Bai J; Li X; Zhao G
Protein Expr Purif; 2012 May; 83(1):1-7. PubMed ID: 22381467
[TBL] [Abstract][Full Text] [Related]
18. Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation.
Patterson JT; Wilson HD; Asano S; Nilchan N; Fuller RP; Roush WR; Rader C; Barbas CF
Bioconjug Chem; 2016 Oct; 27(10):2271-2275. PubMed ID: 27666414
[TBL] [Abstract][Full Text] [Related]
19. Engineering of an anti-epidermal growth factor receptor antibody to single chain format and labeling by Sortase A-mediated protein ligation.
Madej MP; Coia G; Williams CC; Caine JM; Pearce LA; Attwood R; Bartone NA; Dolezal O; Nisbet RM; Nuttall SD; Adams TE
Biotechnol Bioeng; 2012 Jun; 109(6):1461-70. PubMed ID: 22170409
[TBL] [Abstract][Full Text] [Related]
20. Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.
Han X; Cinay GE; Zhao Y; Guo Y; Zhang X; Wang P
Mol Ther; 2017 Nov; 25(11):2466-2476. PubMed ID: 28784559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
